Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

LegoChem Biosciences Inc Lowers FY 2013 Outlook

Thursday, 14 Nov 2013 02:43am EST 

LegoChem Biosciences Inc announced that it has lowered its fiscal year 2013 revenue and operating profit to KRW 3.64 billion and KRW -3.422 billion, from KRW 6.07 billion and KRW -1.669 billion, which was previously announced on May 10, 2013. According to I/B/E/S Estimates, analysts on average are expecting the Company to report revenue of KRW 3.89 billion for the fiscal year 2013. 

Company Quote

-400.0 -2.00%
30 Jan 2015